Antigenics to Webcast 2010 Annual Shareholders Meeting

LEXINGTON, Mass.--(BUSINESS WIRE)-- Antigenics Inc. (NASDAQ: AGEN) invites investors and the general public to its 2010 Annual Shareholders Meeting at 5:00 p.m. ET on Wednesday, May 12. The meeting will be held at the company's headquarters at 3 Forbes Road, Lexington, MA 02421. Registration for attendees starts at 4:30 p.m. ET.

A live webcast will be accessible from the company’s website at www.antigenics.com/webcast/ and will be archived and available for replay approximately two hours after the meeting.

Antigenics is a biotechnology company developing treatments for cancers and infectious diseases. For more information, please visit www.antigenics.com.



CONTACT:

Antigenics
Media: Brad Miles, 212-477-9007 x 17
or
Investors:
Shalini Sharp, 800-962-2436

KEYWORDS:   United States  North America  Massachusetts

INDUSTRY KEYWORDS:   Health  Biotechnology  Infectious Diseases  Oncology  Pharmaceutical

MEDIA:

Logo
 Logo

Suggested Articles

Novartis unveiled more data showing how its asthma combo QMF149 fared against the standard of care: a combination of the same types of drugs.

Johns Hopkins researchers developed a biodegradable polymer to transport large therapies into cells—including genes and even CRISPR.

UCB’s bispecific antibody recently beat Johnson & Johnson’s Stelara at clearing psoriasis symptoms, and now it has bested AbbVie’s Humira, too.